Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of VAQTA and ProQuad in Healthy Children
NCT00326183Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2007
- Primary completion
- Jan 2008
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
01
Overview
A Phase 4 trial of inactivated hepatitis A virus vaccine, varicella virus vaccine live in hepatitis A (HAV), measles, mumps, rubella, chickenpox, sponsored by Merck & Co.. Started Mar 2007; status: completed.
02
Drugs
inactivated hepatitis A virus vaccinevaricella virus vaccine live
03
Conditions
hepatitis A (HAV)measlesmumpsrubellachickenpox
Beyond the preview
Go deeper on NCT00326183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326183.